Skip to content

Pharmacy

Noninvasive exams can help head off liver disease

Noninvasive exams can help head off liver disease

A race is under way among pharmaceutical companies to develop drugs that treat a spectrum of liver diseases, including nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and its more severe form, nonalcoholic steatohepatitis (NAS

Biofourmis forms alliance with Novartis

Biofourmis forms alliance with Novartis

BOSTON – Biofourmis announced Monday it has been selected by Novartis, a global healthcare company, to collaborate on a commercial project for managing patients with heart failure (HF) beginning in Southeast Asia, with potential plans to expand globally.